Diabetes stands for a kind of disease, especially diabetes mellitus, characterized by super high levels of glucose (sugar) in the blood. The product categories for this condition’s management fall within glucose monitoring devices (e.g. lancets, blood glucose meters) and insulin administration devices (e.g. insulin pumps, pens and syringes).
Globally, the Diabetes Care Market trends toward approaching far over EUR 19 billion by end-2018. The market will primarily be jet-propelled by the universal upsurge in the diabetes-stricken population, and the fast adoption tempos of less or non-invasive breakthroughs, including, among others, the EyeSense's blood glucose monitoring (BGM) devices, NBM-200G, 8 MediSensors' optical glucose monitoring technologies, Easy Check’s breath-based glucose testers. The dominating vendors in this marketplace include Roche, LifeScan, Sanofi, Novo Nordisk, Bayer Diabetes, and Lilly.
The research reports within the confines of this Catalogue analyze the Diabetes Care Market’s performance in a worldwide scenario, as well as across different geographies. The researches extensively review major market trends, driving forces and restraints for giving a clearer idea of the market structure. Additionally, the reports give unbiased insights into the competitive environment, major producers of anti-diabetic medications and diabetes devices, key products marketed and those currently in development. The global Diabetes Care Market forecasts are also available in the research reports.
Publications found:
524
Sort by:
The 2027-2032 World Outlook for Diabetes Treatments
US$ 1,195.00
This study covers the world outlook for diabetes treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
288 pages
The 2027-2032 World Outlook for Diabetic Assays
US$ 1,195.00
This study covers the world outlook for diabetic assays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Diabetic Care Devices
US$ 1,195.00
This study covers the world outlook for diabetic care devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Digital Diabetes Management
US$ 1,195.00
This study covers the world outlook for digital diabetes management across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Glucometer
US$ 1,195.00
This study covers the world outlook for glucometer across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the c...
January 2026
287 pages
The 2027-2032 World Outlook for Glucose Meters
US$ 1,195.00
This study covers the world outlook for glucose meters across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Glucose Testing Biosensors
US$ 1,195.00
This study covers the world outlook for glucose testing biosensors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
287 pages
The 2027-2032 World Outlook for Glucose Testing Strips
US$ 1,195.00
This study covers the world outlook for glucose testing strips across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for HbA1c Analyzers
US$ 1,195.00
This study covers the world outlook for HbA1c analyzers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Hemoglobin A1C Monitoring
US$ 1,195.00
This study covers the world outlook for hemoglobin A1C monitoring across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
288 pages
The 2027-2032 World Outlook for Hemoglobin A1C Testing
US$ 1,195.00
This study covers the world outlook for hemoglobin A1C testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
Diabetes Care Drugs & Devices Market - 2025-2033
US$ 3,400.00
Diabetes Care Drugs & Devices Market reached US$ 119.86 billion in 2024 and is expected to reach US$ 244.46 billion by 2033, growing with a CAGR of 8.30% during the forecast period 2026-2033. The Diab...
December 2025
55 pages
US Diabetes Devices Market - 2025-2033
US$ 1,899.00
US Diabetes Devices Market reached US$ 10.25 billion in 2024 and is expected to reach US$ 18.93 billion by 2033, growing with a CAGR of 7.10% during the forecast period 2026-2033. The US Diabetes Devi...
December 2025
45 pages
Insulin Infusion Pumps Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Pump Device, Infusion Set, and Reservoir), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Insulin Infusion Pumps Market, valued at USD 1.55 Billion in 2024, is projected to experience a CAGR of 6.50% to reach USD 2.26 Billion by 2030. Insulin infusion pumps are medical devices p...
December 2025
185 pages
Asia Pacific Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), and End User (Hospitals and Clinics and Self or Homecare)
US$ 3,450.00
The Asia Pacific Continuous Glucose Monitoring Device (CGMD) Market is poised for significant growth, with projections indicating a rise from US$ 2,944.6 million in 2024 to US$ 8,127.0 million by 2031...
November 2025
219 pages
Europe Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), and End User (Hospitals and Clinics and Self or Homecare)
US$ 3,450.00
The Europe Continuous Glucose Monitoring Device (CGMD) Market is poised for significant growth, projected to reach approximately US$ 9,935.2 million by 2031, up from US$ 3,920.3 million in 2024. This...
November 2025
215 pages
Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), and End User (Hospitals and Clinics and Self or Homecare)
US$ 3,450.00
The Middle East & Africa Continuous Glucose Monitoring Device (CGMD) Market is projected to grow significantly, reaching an estimated US$ 918.9 million by 2031, up from US$ 389.6 million in 2024. This...
November 2025
206 pages
North America Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), and End User (Hospitals and Clinics and Self or Homecare)
US$ 3,450.00
The North America Continuous Glucose Monitoring Device (CGMD) Market is projected to grow significantly, reaching an estimated US$ 11,898.8 million by 2031, up from US$ 4,522.1 million in 2024, reflec...
November 2025
201 pages
South & Central America Continuous Glucose Monitoring Device (CGMD) Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensors, Transmitters, and Receivers), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Sites (Fingertip Testing and Alternate Site Testing), and End User (Hospitals and Clinics and Self or Homecare)
US$ 3,450.00
The South & Central America Continuous Glucose Monitoring Device (CGMD) Market is projected to grow significantly, reaching an estimated US$ 2,334.3 million by 2031, up from US$ 931.1 million in 2024,...
November 2025
201 pages
HbA1c Testing Devices Market Outlook 2026-2034: Market Share, and Growth Analysis By Device (Laboratory-based Testing Devices, Point-of-care (POC) Testing Devices), By Technology (Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High-Performance Liquid Chromatography, Others), By End-User
US$ 3,950.00
The HbA1c Testing Devices Market is valued at USD 2.12 billion in 2025 and is projected to grow at a CAGR of 12.9% to reach USD 6.32 billion by 2034. HbA1c Testing Devices Market HbA1c testing devices...
November 2025
160 pages
Self-Monitoring Blood Glucose (Smbg) Devices Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers), By Application
US$ 3,950.00
The Self-Monitoring Blood Glucose (Smbg) Devices Market is valued at USD 15 billion in 2025 and is projected to grow at a CAGR of 10.5% to reach USD 36.7 billion by 2034.The Self-Monitoring Blood Gluc...
October 2025
160 pages
